Literature DB >> 4169542

Serum enzyme changes after hepatic dearterialization in man.

O Almersjö, S Bengmark, L Engevik, L O Hafström, B P Loughridge, L A Nilsson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 4169542      PMCID： PMC1387209          DOI： 10.1097/00000658-196801000-00002

Source DB:  PubMed          Journal:  Ann Surg        ISSN： 0003-4932            Impact factor:   12.969


× No keyword cloud information.
  46 in total

1.  HEPATIC ARTERY LESIONS.

Authors:  R W POSTLETHWAIT; R R HERNANDEZ; M L DILLON
Journal:  Ann Surg       Date:  1964-06       Impact factor: 12.969

2.  EFFECT OF VITAMIN B12 ON LIVER REGENERATION AFTER PARTIAL HEPATECTOMY.

Authors:  S BENGMARK; R OLSSON
Journal:  Gastroenterologia       Date:  1963

3.  Serum glutamic oxaloacetic transaminase after hepatic artery ligatature.

Authors:  A R FAHMY; M TALAAT; M A ZACHARY
Journal:  Experientia       Date:  1960-08-15

4.  A biochemical dissection of ischemic liver necrosis.

Authors:  E E MASON; R A LEE; J SMITH; C DIERKS
Journal:  Surgery       Date:  1959-05       Impact factor: 3.982

5.  The use of alpha-(N-gamma-dL-glutamyl)-aminonitriles for the colorimetric determination of a specific peptidase in blood serum.

Authors:  A SZEWCZUK; M ORLOWSKI
Journal:  Clin Chim Acta       Date:  1960-09       Impact factor: 3.786

6.  Serum glutamic oxalacetic transaminase as an index of hepatocellular integrity.

Authors:  D W MOLANDER; F WROBLEWSKI; J S LADUE
Journal:  J Lab Clin Med       Date:  1955-12

7.  Serum glutamic oxalacetic transaminase activity as an index of liver cell injury: a preliminary report.

Authors:  F WROBLEWSKI; J S LADUE
Journal:  Ann Intern Med       Date:  1955-08       Impact factor: 25.391

8.  Ligation of the hepatic and splenic arteries in the treatment of portal hypertension with a report of six cases; preliminary report.

Authors:  W F REINHOFF
Journal:  Bull Johns Hopkins Hosp       Date:  1951-04

9.  Therapeutic hepatic artery ligation in patients with secondary liver tumors.

Authors:  L A Nilsson
Journal:  Rev Surg       Date:  1966 Sep-Oct

10.  Low molecular weight dextran and high pressure oxygen in the treatment of ligation of the hepatic artery in dogs.

Authors:  J P Hogan; E H Ellison
Journal:  Am J Surg       Date:  1966-06       Impact factor: 2.565
View more
  10 in total

1.  Hepatic artery ligation for metastastic leiomyosarcoma of the liver.

Authors:  N Nagasue; H Murakami; S Araki; K Ayabe
Journal:  Jpn J Surg       Date:  1972-06

2.  Treatment of primary and secondary liver cancer by hepatic artery ligation and infusion chemotherapy.

Authors:  J G Fortner; R J Mulcare; A Solis; R C Watson; R B Golbey
Journal:  Ann Surg       Date:  1973-08       Impact factor: 12.969

3.  Hepatic artery occlusion following hepatic artery catheterization.

Authors:  R J Lucas; O Tumacder; G S Wilson
Journal:  Ann Surg       Date:  1971-02       Impact factor: 12.969

4.  Changes of hepatic function after hepatic artery ligation.

Authors:  X P Chen; Z D Wu
Journal:  Acta Acad Med Wuhan       Date:  1983

5.  Changes in liver function after hepatic dearterialization in man.

Authors:  N Nagasue; H Murakami; K Ayabe; K Ichimaru; S Araki
Journal:  Jpn J Surg       Date:  1973-03

6.  Creatine kinase isoenzymes: biochemical findings after therapeutical embolization of the hepatic artery in two patients with liver metastasis of an islet cell carcinoma or a carcinoid tumor.

Authors:  E SiragEldin; R Klapdor
Journal:  Klin Wochenschr       Date:  1985-03-15

7.  Successful treatment of hepatic artery aneurysm with erosion into the common duct.

Authors:  S Ariyan; C E Cahow; F L Greene; H C Stansel
Journal:  Ann Surg       Date:  1975-08       Impact factor: 12.969

8.  Effect on liver tumor growth in rats of allopurinol and 5-fluorouracil in combination with hepatic artery ligation.

Authors:  G Carlsson; B Gustavsson; L Hafström
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

9.  The influence of female mice age on biodistribution and biocompatibility of citrate-coated magnetic nanoparticles.

Authors:  Willie O Pinheiro; Maria L Fascineli; Gabriel R Farias; Frederico H Horst; Laise Rodrigues de Andrade; Luis Henrique Corrêa; Kelly Grace Magalhães; Marcelo Henrique Sousa; Marcos C de Almeida; Ricardo B Azevedo; Zulmira G M Lacava
Journal:  Int J Nanomedicine       Date:  2019-05-08

10.  Antitumor activity of photodynamic therapy performed with nanospheres containing zinc-phthalocyanine.

Authors:  Flávia Arruda Portilho; Cláudio Eduardo de Oliveira Cavalcanti; Ana Luisa Miranda-Vilela; Luciana Landim Carneiro Estevanato; João Paulo Figueiró Longo; Maria de Fátima Menezes Almeida Santos; Anamélia Lorenzetti Bocca; Olímpia Paschoal Martins; Andreza R Simioni; Paulo César Morais; Ricardo Bentes Azevedo; Antonio Claudio Tedesco; Zulmira Guerrero Marques Lacava
Journal:  J Nanobiotechnology       Date:  2013-12-16       Impact factor: 10.435
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.